Skip to main content
. 2014 Jan 20;2014(1):CD010927. doi: 10.1002/14651858.CD010927

5.10. Analysis.

5.10

Comparison 5 Dihydroartemisinin‐piperaquine versus Artesunate plus amodiaquine, Outcome 10 Other adverse events: Cardio‐respiratory.